Navigation Links
GenVault Opens Japanese Subsidiary to Better Address Global Biobanking Market Growth
Date:1/26/2009

GenVault's energy and space efficient technologies ideally suit the needs of the Japanese Biobanking community, and create a new paradigm for eco-friendly, sustainable Biobanking initiatives.

CARLSBAD, Calif., Jan. 26 /PRNewswire/ -- GenVault Corporation today announces the opening of its newly-formed Japanese subsidiary in order to better serve the needs of the expanding Biobanking market and its growing customer base in Japan. GenVault Japan KK will be responsible for the marketing, selling and technical support of the full range of GenVault products and services in Japan.

GenVault is also delighted to announce that Mr. Junya Tominaga has joined the company in the role of Managing Director, GenVault Japan. Mr. Tominaga has over twenty years of senior management experience in the Japanese life science market place, most recently serving as the Managing Director of Illumina, Japan. Prior to this Mr. Tominaga held positions as Managing Director of Molecular Dynamics Japan and Clontech Japan.

"GenVault is very excited to be establishing a direct presence in Japan. We feel our products and technologies are particularly well suited for use in Japan, and bring strong advantages in terms of space and energy savings. We look forward to serving the needs of our Japanese customers," commented Mark J. Sutherland, Sr. Vice-President of Business Development for GenVault Corporation.

GenVault Japan is located in the ARK Mori Building in the Akasaka district of Tokyo and can be contacted at TEL: +81 (03) 4360-8225 and FAX +81 (03) 4360-8201

About GenVault

GenVault is the global leader in providing biosample workflow, transport, and storage solutions for genomic medicine, discovery and identification. Today, GenVault is empowering over 150 pharmaceutical companies, medical centers, academic institutions and law enforcement agencies to more fully leverage the rapidly growing genomics industry. As a scalable and reliable alternative to traditional freezers and DNA purification systems, the company's dry-state platform enables the extraction, preservation, recovery, and distribution of DNA at room temperature. Future systems will also accommodate proteins and RNA to provide a comprehensive solution. From GenPlate to the Dynamic Archive, GenVault is continuously developing and refining best practices for DNA sample management and preservation. For more information visit GenVault at www.genvault.com.

Contact: Bret Dash

Tel : 760 717 3774

bdash@genvault.com


'/>"/>
SOURCE GenVault Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. GenVault to Present at the BIOCOM Investor Conference
2. Mark Sutherland Joins GenVault as Senior Vice President, Business Development
3. GenVault Corporation Launches GenTegra(TM) DNA
4. GenVault Expands Scientific Advisory Board
5. Paul J. Mirabella, President and CEO of Naviscan PET Systems Inc., Joins GenVaults Board of Directors
6. Mark Ostrowski Joins GenVault as Vice President of Sales and Marketing
7. McGill University Purchases GenVaults Personal Archive System to Manage Rare Cancer Samples
8. GenVault and the National Center for Forensic Science to Present Novel Technology for Room Temperature Storage of RNA
9. David Barker, Former Illumina CSO, Joins GenVaults Scientific Advisory Board
10. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
11. DuPont Opens Research & Development Center in India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, ... after being treated for breast cancer benefitted from an injection of stem cells derived ... debilitating, frequent side effect of cancer treatment. , Lymphedema refers to the ...
Breaking Biology Technology:
(Date:6/15/2016)... 2016 Transparency Market Research ... Market by Application Market - Global Industry Analysis Size Share ... the report, the  global gesture recognition market  was ... is estimated to grow at a CAGR of ... Increasing application of gesture recognition technology ...
(Date:6/3/2016)... June 3, 2016 ... Nepal hat ein ... hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und ... der Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche ... im Januar teilgenommen, aber Decatur wurde als ...
(Date:6/1/2016)... -- Favorable Government Initiatives Coupled With Implementation ... to Boost Global Biometrics System Market Through 2021  ... " Global Biometrics Market By Type, By End ... - 2021", the global biometrics market is projected to ... growing security concerns across various end use sectors such ...
Breaking Biology News(10 mins):